-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Teladoc Health, Raises Price Target to $10

Benzinga·10/30/2026 23:23:03
JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $8 to $10.